跳至主要内容
临床试验/IRCT20191218045795N8
IRCT20191218045795N8招募中3 期

The effect of L-carnitine as an adjunct on cognitive abilities of patients with schizophrenia

Sanandaj University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Schizophrenia according to DSM-5
  • Absence of any other disease that negatively affects the patient's cognitive processes (dementia, hypothyroidism, intellectual disability, ID... based on clinical interview)
  • receiving a fixed dose of drugs such as anticholinergics (bipyridine...) and benzodiazepines during the last 1 month
  • Receiving regular standard treatment and having a stable and controlled clinical condition during the last 1 month

排除标准

  • Coexistence of another psychiatric disorder according to DSM-5
  • Received ECT in the past 2 months
  • Coexistence of substance abuse disorder and methadone according to DSM-5
  • Taking any medication that is prescribed due to cognitive problems or significantly affects the patient's cognitive processes

研究者

发起方
Sanandaj University of Medical Sciences

相似试验